Main description:

Choose the drug handbook trusted by nurses for more than 35 years! Mosby's 2023 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled - including 35 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on both common and life-threatening side effects. From nursing pharmacology expert Linda Skidmore-Roth, this perennial bestseller proves there is a difference in drug guides.

More than 5,000 generic and trade-name drugs are profiled, covering almost every drug you will administer in practice or in clinicals.
Safety Alert icon highlights the most critical drug interactions and side effects.
Black Box Warnings provide alerts to FDA warnings of dangerous or life-threatening drug reactions.
Nursing Process steps are used as the framework for organizing all nursing care information.
Coverage of IV drug administration highlights dosage and IV administration instructions, including safety considerations and Y-site, syringe, and additive compatibilities.
Side effects information is organized by body system and identified as common or life threatening, showing signs to watch for during assessments.
Alphabetical organization by generic name provides quick and easy access to specific drugs, and a full-color design highlights important information.
Complete pharmacokinetic information includes the mechanism and absorption of the drug as well as its action, duration, and excretion.
Overview of drug categories explains the safe administration of common classes of drugs, as well as their common side effects and interactions.
Flexible, water-resistant cover provides durability in the clinical setting.

NEW! Drug monographs for 35 new FDA-approved medications equip you with the latest drug information including generic names, trade names, pronunciations, do-not-confuse drugs, action, uses, contraindications, precautions, dosages and routes, side effects, pharmacokinetics, interactions (including drug/herb, drug/food and drug/lab test), nursing considerations, treatment of overdose, patient/family teaching, and more.
NEW! Updates on drug therapies provide the most current information.

Contents:

INDIVIDUAL DRUG MONOGRAPHS
APPENDIXES
A. Selected New Drugs
abametapir
aducanumab-avwa
afamelanotide
anifrolumab-fnia
asciminib
atogepant
avacopan
avapritinib
belumosudil
belzutifan
bempedoic acid
brolucizumab-dbll
difelikefalin
dostarlimab-gxly
eculizumab
efavirenz/emtricitabine/tenofovir
elapegademase-ivir
elbasvir/grazoprevir
elexacaftor/tezacaftor/ivacaftor and ivacaftor
emtricitabine/rilpivirine/tenofovir alafenamide
enalapril/hydrochlorothiazide
ephedrine
factor IX complex
factor IX, human
factor IX, recombinant
finerenone
fluocinolone
fluocinonide
lonapegsomatropin-tcgd
loncastuximab tesirine-lpyl
maribavir
mobocertinib
odevixibat
ropeginterferon alfa-2b
tisotumab vedotin-tftv
vosoritide
B. Ophthalmic, Nasal, Topical, and Otic Products
C. Vaccines and Toxoids
D. Recent FDA Drug Approvals
INDEX
EVOLVE WEBSITE
. Additional Monographs
. Drug Categories